International scientific guideline: Questions and Answers: Positions on specific questions addressed to the pharmacokinetics working party

About this guideline

Categories: Clinical efficacy and safety | Clinical pharmacology and pharmacokinetics | Product-specific bioequivalence

Access this international scientific guideline

Further information: For information: 1 June 2014

For more information see International scientific guidelines adopted in Australia.

Where EU guidelines adopted in Australia include references to EU legislation (including EC Directives and Regulations), the requirements contained in the referenced EU legislation are not applicable to the evaluation of medicines by the TGA.